Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors
Xiaojun Ju1, Piotr Gaca1, Wanlin Fan1
1Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Abstract:
Malignant tumors of the eyelids and ocular surface are common ocular malignancies. At present, surgical treatment is mostly the first choice for these types of tumors. However, postoperative tumor recurrence and metastasis are still regarded as failures in the treatment of such malignancies. Based on this, malignant tumors of the eyelid and ocular surface are sometimes accompanied by local adjuvant chemotherapy and systemic chemotherapy to treat patients with relapse, invasion of adjacent tissues, and systemic metastases. Still, drug resistance greatly affects the treatment effect. This review lists several mechanisms of recurrence and metastasis of ocular surface and eyelid tumors after surgery, as well as mechanisms that may lead to non-surgical treatment or drug resistance.
Insights
Eyelid and ocular surface tumors often recur after surgery. This review explores recurrence, metastasis, and drug resistance mechanisms to improve cancer treatment outcomes.
Area of Science:
- Ophthalmology
- Oncology
- Cancer Biology
Background:
- Malignant tumors of the eyelids and ocular surface are common ocular malignancies.
- Surgical treatment is the primary approach, but recurrence and metastasis remain significant challenges.
- Adjuvant and systemic chemotherapy are used for advanced cases, yet drug resistance limits efficacy.
Purpose of the Study:
- To review the mechanisms of recurrence and metastasis in eyelid and ocular surface tumors post-surgery.
- To explore factors contributing to non-surgical treatment failure and drug resistance.
Main Methods:
- Literature review of studies on ocular surface and eyelid malignancies.
- Analysis of mechanisms underlying tumor recurrence, metastasis, and drug resistance.
- Synthesis of current understanding of treatment challenges.
Main Results:
- Identified key pathways and factors driving tumor recurrence and metastasis after surgical resection.
- Highlighted cellular and molecular mechanisms contributing to chemotherapy resistance.
- Discussed challenges in achieving successful non-surgical treatment outcomes.
Conclusions:
- Understanding recurrence, metastasis, and drug resistance mechanisms is crucial for improving treatment strategies.
- Further research into novel therapeutic targets and combination therapies is warranted.
- Developing strategies to overcome drug resistance is essential for enhancing patient survival and quality of life.
Related Concept Videos
Treatment Resistant Cancers
Accessory Structures of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

